Genitourinary Radiology: Page 7

Imaging proves vital when assessing COVID-19 kidney complications
By Kate Madden Yee
Imaging plays a central role in evaluating and tracking kidney complications due to COVID-19 -- and radiologists must not only understand what to look for but also make themselves readily available to their referring colleagues, Italian experts told ECR 2021 attendees.
March 10, 2021
2021 03 11 17 45 5637 2021 03 11 Ecr Renal Covid Image1 20210311171748
Telix secures Czech approval for prostate PET radiopharmaceutical
By AuntMinnieEurope.com staff writers
Telix Pharmaceuticals has received approval from the Czech Republic's Ministry of Health for use of its Illuccix radiopharmaceutical for prostate cancer PET imaging in that country.
February 18, 2021
2021 02 19 01 09 5836 Cancer Cells Prostate 400
French groups issue new guidelines to promote safe contrast use
By Frances Rylands-Monk
French nephrology societies and the national radiology society have published guidelines on the safe use of contrast media in the wake of guidance from the European Society of Urogenital Radiology.
February 14, 2021
2021 02 12 17 02 4497 French Flag Splashes 400
U.K. team backs shorter MRI exam for prostate cancer screening
By Kate Madden Yee
A research team from Imperial College London has reported that a short, biparametric MRI protocol without contrast detected twice as many clinically significant prostate cancers compared with prostate-specific antigen (PSA) testing. The authors published their results on 11 February in JAMA Oncology.
February 14, 2021
2021 02 12 16 33 4471 3 D Prostate Cancer Viral 400
Blue Earth buys therapeutic rights to rhPSMA technology
By AuntMinnieEurope.com staff writers
Bracco molecular imaging subsidiary Blue Earth Diagnostics has acquired exclusive, worldwide rights to therapeutic applications of radiohybrid prostate-specific membrane antigen (rhPSMA) technology developed by German radiopharmaceutical firm Scintomics and the Technical University of Munich.
January 4, 2021
2019 12 19 00 53 5252 Hands Shaking Deal 400
Machine learning helps identify cystic renal lesions
By Erik L. Ridley
A machine-learning model based on CT radiomics analysis has achieved excellent diagnostic performance in distinguishing benign from malignant complex cystic renal lesions, outperforming the current Bosniak classification system, Canadian and French investigators reported at the RSNA 2020 meeting.
December 6, 2020
2019 01 15 00 00 8588 Kidneys 400
German group refines PET technique for prostate cancer
By Brian Casey
Researchers from Essen have used a PET-based optical imaging method known as Cerenkov luminescence imaging to highlight the presence of cancer cells after prostate cancer surgery. They published their results in the October edition of the Journal of Nuclear Medicine.
October 12, 2020
2020 10 12 17 13 8441 2020 10 08 Cerenkov 20201012175532
Scottish team strives to speed up prostate MRI reporting
By Philip Ward
Radiologists in Scotland have adopted a rigorous approach to quality management to improve the scheduling and reporting of prebiopsy prostate MRI exams. They narrowly failed to meet their 2019 target of reporting 90% of all requested exams within 28 days, but feel they're heading the right way.
October 11, 2020
2018 10 15 20 04 2505 2018 10 16 Jfr Irm Multiparametrique Thumb
Moscow PET facilities make change to prostate scans
By AuntMinnieEurope.com staff writers
Providers of PET services in Moscow have started using a radiopharmaceutical agent, F-18 prostate-specific membrane antigen, for a more accurate diagnosis of prostate cancer, according to a statement issued by the Research and Practical Clinical Center of Diagnostics and Telemedicine Technologies in Russia.
October 4, 2020
2019 05 03 20 23 2154 Prostate 3 D 400
Post-treatment SPECT/CT monitors radionuclide dose
By Kate Madden Yee
A research group from the Peter MacCallum Cancer Center in Melbourne, Australia, has pioneered a technique that uses a follow-up SPECT/CT examination after radionuclide therapy to personalize the radiation dose delivered to a patient.
September 6, 2020
2018 07 20 22 27 4483 Australian Flag 400
ViewRay highlights results from prostate cancer study
By AuntMinnieEurope.com staff writers
Image-guided radiation therapy vendor ViewRay is highlighting the results of a clinical study on the use of its MR-guided radiation therapy technology for treating men with prostate cancer.
June 24, 2020
2019 09 17 17 11 0207 Viewray Astro 2019
ITM signs supply deals with Point Biopharma
By AuntMinnieEurope.com staff writers
German radiopharmaceutical group ITM Isotopen Technologien München has signed supply agreements with radiopharmaceutical Point Biopharma for ITM's EndolucinBeta radiopharmaceutical precursor.
June 23, 2020
2016 08 24 09 43 13 537 Hands Shaking V3 400
Previous Page
Page 7 of 22
Next Page